SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 129 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $268,000 | -44.7% | 73,810 | 0.0% | 0.05% | -48.9% |
| Q2 2016 | $485,000 | -4.2% | 73,810 | -7.3% | 0.09% | -11.5% |
| Q1 2016 | $506,000 | +10.5% | 79,600 | +4.7% | 0.10% | -11.9% |
| Q4 2015 | $458,000 | +2.5% | 76,000 | +1.7% | 0.12% | -2.5% |
| Q3 2015 | $447,000 | -5.9% | 74,700 | +7.5% | 0.12% | 0.0% |
| Q2 2015 | $475,000 | +12.6% | 69,500 | 0.0% | 0.12% | +8.0% |
| Q1 2015 | $422,000 | -12.4% | 69,500 | 0.0% | 0.11% | +4.7% |
| Q4 2014 | $482,000 | -14.8% | 69,500 | 0.0% | 0.11% | -18.9% |
| Q3 2014 | $566,000 | +39.1% | 69,500 | +39.0% | 0.13% | +37.5% |
| Q2 2014 | $407,000 | +3.8% | 50,000 | 0.0% | 0.10% | +2.1% |
| Q1 2014 | $392,000 | -11.5% | 50,000 | 0.0% | 0.09% | -21.7% |
| Q4 2013 | $443,000 | +5.7% | 50,000 | 0.0% | 0.12% | +11.1% |
| Q3 2013 | $419,000 | +12.3% | 50,000 | 0.0% | 0.11% | -0.9% |
| Q2 2013 | $373,000 | – | 50,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |